ES529492A0 - Un procedimiento para la preparacion de nizatidina - Google Patents

Un procedimiento para la preparacion de nizatidina

Info

Publication number
ES529492A0
ES529492A0 ES529492A ES529492A ES529492A0 ES 529492 A0 ES529492 A0 ES 529492A0 ES 529492 A ES529492 A ES 529492A ES 529492 A ES529492 A ES 529492A ES 529492 A0 ES529492 A0 ES 529492A0
Authority
ES
Spain
Prior art keywords
nizatidine
preparation
procedure
methyl
ylmethylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES529492A
Other languages
English (en)
Spanish (es)
Other versions
ES8601941A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23843341&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES529492(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES529492A0 publication Critical patent/ES529492A0/es
Publication of ES8601941A1 publication Critical patent/ES8601941A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Credit Cards Or The Like (AREA)
ES529492A 1983-02-07 1984-02-06 Un procedimiento para la preparacion de nizatidina Expired ES8601941A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46429683A 1983-02-07 1983-02-07

Publications (2)

Publication Number Publication Date
ES529492A0 true ES529492A0 (es) 1985-11-01
ES8601941A1 ES8601941A1 (es) 1985-11-01

Family

ID=23843341

Family Applications (1)

Application Number Title Priority Date Filing Date
ES529492A Expired ES8601941A1 (es) 1983-02-07 1984-02-06 Un procedimiento para la preparacion de nizatidina

Country Status (27)

Country Link
EP (1) EP0116452B1 (US06380249-20020430-C00197.png)
JP (1) JPS59152378A (US06380249-20020430-C00197.png)
KR (1) KR860000767B1 (US06380249-20020430-C00197.png)
AT (1) ATE84530T1 (US06380249-20020430-C00197.png)
AU (1) AU559639B2 (US06380249-20020430-C00197.png)
BG (1) BG45216A3 (US06380249-20020430-C00197.png)
CA (1) CA1221369A (US06380249-20020430-C00197.png)
CS (1) CS240994B2 (US06380249-20020430-C00197.png)
DD (1) DD216459A5 (US06380249-20020430-C00197.png)
DE (1) DE3486032T2 (US06380249-20020430-C00197.png)
DK (2) DK164501C (US06380249-20020430-C00197.png)
EG (1) EG17702A (US06380249-20020430-C00197.png)
ES (1) ES8601941A1 (US06380249-20020430-C00197.png)
FI (1) FI840474A (US06380249-20020430-C00197.png)
GB (1) GB2134521B (US06380249-20020430-C00197.png)
GR (1) GR81755B (US06380249-20020430-C00197.png)
HU (2) HU190527B (US06380249-20020430-C00197.png)
IE (1) IE56763B1 (US06380249-20020430-C00197.png)
IL (1) IL70880A (US06380249-20020430-C00197.png)
NZ (1) NZ207046A (US06380249-20020430-C00197.png)
PH (1) PH19941A (US06380249-20020430-C00197.png)
PL (1) PL138793B1 (US06380249-20020430-C00197.png)
PT (1) PT78063A (US06380249-20020430-C00197.png)
RO (1) RO87706A (US06380249-20020430-C00197.png)
SU (1) SU1303028A3 (US06380249-20020430-C00197.png)
UA (1) UA6020A1 (US06380249-20020430-C00197.png)
ZA (1) ZA84869B (US06380249-20020430-C00197.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0230127A1 (en) * 1985-12-18 1987-07-29 Eli Lilly And Company Synthesis of nizatidine
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Also Published As

Publication number Publication date
DD216459A5 (de) 1984-12-12
GB2134521A (en) 1984-08-15
BG45216A3 (US06380249-20020430-C00197.png) 1989-04-14
HU190527B (en) 1986-09-29
PL138793B1 (en) 1986-11-29
PL246097A1 (en) 1985-06-04
JPS59152378A (ja) 1984-08-31
CA1221369A (en) 1987-05-05
EG17702A (en) 1991-03-30
EP0116452B1 (en) 1993-01-13
GB8403109D0 (en) 1984-03-07
FI840474A0 (fi) 1984-02-06
NZ207046A (en) 1986-06-11
PT78063A (en) 1984-03-01
KR860000767B1 (ko) 1986-06-23
DK21292D0 (da) 1992-02-19
FI840474A (fi) 1984-08-08
GR81755B (US06380249-20020430-C00197.png) 1984-12-12
DK164906B (da) 1992-09-07
CS81284A2 (en) 1985-06-13
SU1303028A3 (ru) 1987-04-07
DK164501B (da) 1992-07-06
GB2134521B (en) 1986-10-01
ZA84869B (en) 1985-09-25
JPH0576473B2 (US06380249-20020430-C00197.png) 1993-10-22
DK51984A (da) 1984-08-08
DK164906C (da) 1993-01-25
AU2421584A (en) 1984-08-16
RO87706A (ro) 1985-10-31
ES8601941A1 (es) 1985-11-01
KR840007591A (ko) 1984-12-08
IL70880A (en) 1987-01-30
IL70880A0 (en) 1984-05-31
AU559639B2 (en) 1987-03-19
DE3486032T2 (de) 1993-05-19
DK51984D0 (da) 1984-02-06
ATE84530T1 (de) 1993-01-15
IE840274L (en) 1984-08-07
DK21292A (da) 1992-02-19
EP0116452A3 (en) 1987-04-29
EP0116452A2 (en) 1984-08-22
RO87706B (ro) 1985-10-01
IE56763B1 (en) 1991-12-04
DK164501C (da) 1992-11-23
PH19941A (en) 1986-08-14
DE3486032D1 (de) 1993-02-25
UA6020A1 (uk) 1994-12-29
HU194198B (en) 1988-01-28
CS240994B2 (en) 1986-03-13

Similar Documents

Publication Publication Date Title
IT1123753B (it) 5-(4-piridil)-6-(4-fluorofenil)-2,3-diidromidazo (2,1-b) tiazolo e procedimento per la sua preparazione
PT89109A (pt) Metodo para melhorar a funcao cognitiva por administracao de d-ciclosserina e suas pro-drogas
ATE21105T1 (de) 7-oxo-4-thia-1-aza(3.2.0)heptan- und 7-oxo-4-thia-1-aza-(3.2.0)hept-2-en-derivate.
GB2123830A (en) Trisubstituted diazo compounds
ES529492A0 (es) Un procedimiento para la preparacion de nizatidina
PT88355A (pt) Processo para a conversao da estrutura cristalina polimorfica do cloridrato de buspirona
ATE33388T1 (de) Verfahren zur herstellung von 2(hydrocarbyldithio)-5-mercapto-1,3,4thiadiazolen.
ES529736A0 (es) Un procedimiento para la preparacion de 3-formil-2-nitrometilen-tetrahidro-2h-1, 3-tiazina
FR2520083B1 (fr) Procede pour la fabrication de joints armes, notamment de joints de culasse
ES8301942A1 (es) Un procedimiento para la preparacion de acidos dialupilos s-sustituidos.
ATE46691T1 (de) Synthese von bicyclischen aromatischen sulfonylchloriden.
DK36689D0 (da) Fremgangsmaade til fremstilling af et 16-methoxy-16-methyl-prostaglandin e1-derivat, samt ved fremgangsmaaden anvendelige mellemprodukter
ECSP941119A (es) Compuestos antihipercolesterolemicos
PT91562A (pt) Process for preparing hemiphosphate hemihydrate of 2-(1-pentyl--3-guanidino-4-imidazolyl) thiazole
ES557634A0 (es) Un procedimiento para la produccion de un compuesto de tiazolidindiona hipoglicemico.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050712